Abstract
[This corrects the article DOI: 10.18632/oncotarget.20293.].
Highlights
Oncotarget, 2019, Vol 10, (No 8), pp: 917-917
an open-access article distributed under the terms of the Creative Commons Attribution License 3.0
These authors have contributed to this work
Summary
Oncotarget, 2019, Vol 10, (No 8), pp: 917-917 Correction: The prognostic significance of combined androgen receptor, E-Cadherin, Ki67 and CK5/6 expression in patients with triple negative breast cancer
Sign-in/Register to view highlights & summary Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
